Special Issue "Latest Advances on Nanoparticles for Modern Biomedicine"
Deadline for manuscript submissions: 31 March 2024 | Viewed by 4052
Capitalizing on the properties of materials at the nanoscale, modern biomedicine takes as its basis nanomedicine, a promising field that uses nanoparticles as carriers of drugs and agents for the diagnostics of socially significant diseases, including cancer.
The properties of nanoparticles, such as their high surface area to volume ratio, their ability to engage in passive/active guidance, high load-bearing capacity, significant interaction with biological tissues, unique surface properties, good biocompatibility and biodegradability, etc., make them useful for many applications. Nanoparticles can also be readily tailored to provide a combination of therapeutic effects either by themselves or via the encapsulation of multiple drugs. In addition, they can be applied in multiple imaging modalities, such as MRI, optical imaging, CT and SPECT imaging, and photoacoustic imaging, to enable image-guided precision therapy and monitor therapeutic action in real time. Promising results have been obtained using therapeutic and imaging molecules capable of recognizing different tumor-associated antigens on a tumor cell. The proposed approaches apply personalized nanoteranostics, which increases the selectivity and effectiveness of treatment.
This Special Issue of the International Journal of Molecular Sciences will discuss, collect, and offer recent highlights and advances in the synthesis, characterization, and functionalization of nanoparticles and their composites, the study and application of their multimodal properties, and different types of nanoformulations for nanotheranostics, including in nuclear nanomedicine and radiology.
Dr. Irina Zavestovskaya
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- targeted therapy
- laser-ablative synthesis
- drug delivery